{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:08:32Z","timestamp":1789052912015,"version":"build-2803163510"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010418","name":"IITP","doi-asserted-by":"publisher","award":["RS-2026-25529927"],"award-info":[{"award-number":["RS-2026-25529927"]}],"id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) has been established to classify steatotic liver disease more accurately. We investigated the association between MASLD and long-term kidney transplant outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Kidney transplant recipients who underwent national health screening programs from 2009 to 2017 and with follow-up until 2021 were identified using the Korean National Health Insurance Service data. MASLD was defined based on cardiometabolic criteria and the fatty liver index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 8326 kidney transplant recipients, 2027 (24.3%) had MASLD, 25 (0.3%) had MASLD with increased alcohol intake, and 419 (5.0%) had MASLD with other liver diseases. The incidence rates of graft failure (17.5 vs. 11.3, P\u00a0&amp;lt;\u00a0.001) and mortality (12.5 vs. 8.9 per 1000 person-years, P\u00a0&amp;lt; .001) were significantly higher in the MASLD group than in those without steatotic liver disease. After adjusting for demographics, lifestyle, comorbidities, estimated glomerular filtration rate, proteinuria, and acute rejection, the adjusted hazard ratios for graft failure and mortality were 1.23 (95% confidence interval, 1.03\u20131.46) and 1.03 (95% confidence interval, 0.85\u20131.25), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identified MASLD as a significant risk factor for graft failure in kidney transplant recipients, highlighting the need for MASLD screening and management in kidney transplant recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag294","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:32:53Z","timestamp":1788219173000},"source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysfunction-associated steatotic liver disease predicts graft failure in kidney transplant recipients"],"prefix":"10.1093","volume":"19","author":[{"given":"Kyungho","family":"Lee","sequence":"first","affiliation":[{"name":"Sungkyunkwan University School of Medicine Division of Nephrology, Department of Medicine, Samsung Medical Center, , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yebin","family":"Park","sequence":"additional","affiliation":[{"name":"Soongsil University Department of Statistics and Actuarial Science, , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojin","family":"Jeon","sequence":"additional","affiliation":[{"name":"Sungkyunkwan University School of Medicine Division of Nephrology, Department of Medicine, Samsung Medical Center, , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-0177","authenticated-orcid":false,"given":"Junseok","family":"Jeon","sequence":"additional","affiliation":[{"name":"Sungkyunkwan University School of Medicine Division of Nephrology, Department of Medicine, Samsung Medical Center, , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Eun","family":"Lee","sequence":"additional","affiliation":[{"name":"Sungkyunkwan University School of Medicine Division of Nephrology, Department of Medicine, Samsung Medical Center, , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooseong","family":"Huh","sequence":"additional","affiliation":[{"name":"Sungkyunkwan University School of Medicine Division of Nephrology, Department of Medicine, Samsung Medical Center, , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[{"name":"Soongsil University Department of Statistics and Actuarial Science, , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ryoun","family":"Jang","sequence":"additional","affiliation":[{"name":"Sungkyunkwan University School of Medicine Division of Nephrology, Department of Medicine, Samsung Medical Center, , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026091010265091000_bib1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"2026091010265091000_bib2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41575-025-01045-z","article-title":"Metabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment","volume":"22","author":"Byrne","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026091010265091000_bib3","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"2026091010265091000_bib4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026091010265091000_bib5","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"KDIGO 2024","year":"2024","journal-title":"Kidney Int"},{"key":"2026091010265091000_bib6","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1111\/ajt.16463","article-title":"Long-term kidney transplant graft survival-making progress when most needed","volume":"21","author":"Poggio","year":"2021","journal-title":"Am J Transplant"},{"key":"2026091010265091000_bib7","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/ndt\/gfaf066","article-title":"A meta-analysis of graft survival, patient survival, and delayed graft function in first-time and repeat kidney transplants","volume":"40","author":"Kanbay","journal-title":"Nephrol Dial Transplan"},{"key":"2026091010265091000_bib8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2215\/CJN.14620920","article-title":"Managing patients with failing kidney allograft: many questions remain","volume":"17","author":"Davis","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026091010265091000_bib9","doi-asserted-by":"publisher","first-page":"e2349538","DOI":"10.1001\/jamanetworkopen.2023.49538","article-title":"Metabolic risk profile and graft function deterioration 2 years after kidney transplant","volume":"6","author":"Yan","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026091010265091000_bib10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","article-title":"Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data","volume":"32","author":"Kim","year":"2017","journal-title":"J Korean Med Sci"},{"key":"2026091010265091000_bib11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"2026091010265091000_bib12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","article-title":"External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study","volume":"11","author":"Koehler","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091010265091000_bib13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026091010265091000_bib14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von\u00a0Elm","year":"2007","journal-title":"Lancet"},{"key":"2026091010265091000_bib15","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.transproceed.2014.02.017","article-title":"Nonalcoholic fatty liver disease in renal transplant recipients proven by transient elastography","volume":"46","author":"Mikolasevic","year":"2014","journal-title":"Transplant Proc"},{"key":"2026091010265091000_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11739-025-03967-7","article-title":"Metabolic associated steatotic liver disease in renal transplant recipients: a retrospective cohort study","volume":"21","author":"Secondulfo","year":"2025","journal-title":"Intern Emerg Med"},{"key":"2026091010265091000_bib17","first-page":"14","article-title":"Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: a cross-sectional study using FibroScan","volume":"4","author":"Yesil","year":"2023","journal-title":"Hepatol Forum"},{"key":"2026091010265091000_bib18","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","article-title":"Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis","volume":"103","author":"Saeed","year":"2019","journal-title":"Transplantation"},{"key":"2026091010265091000_bib19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"2026091010265091000_bib20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41392-020-0105-2","article-title":"The circFASN\/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis","volume":"5","author":"Zhang","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"2026091010265091000_bib21","first-page":"316","article-title":"Influence of tacrolimus on bile acid and lipid composition in continuously drained bile using a rat model. Comparative study with cyclosporine","volume":"12","author":"Mizuta","year":"1999","journal-title":"Transpl Int"},{"key":"2026091010265091000_bib22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/TP.0000000000003867","article-title":"Management of diabetes in candidates for liver transplantation and in transplant recipients","volume":"106","author":"Brodosi","year":"2022","journal-title":"Transplantation"},{"key":"2026091010265091000_bib23","first-page":"G1141","article-title":"Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation","volume":"272","author":"Lett\u00e9ron","year":"1997","journal-title":"Am J Physiol"},{"key":"2026091010265091000_bib24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.07.020","article-title":"Glucocorticoids and non-alcoholic fatty liver disease","volume":"154","author":"Woods","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026091010265091000_bib25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/MNH.0000000000000673","article-title":"Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation","volume":"30","author":"Tantisattamo","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026091010265091000_bib26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12916-023-02891-x","article-title":"The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank","volume":"21","author":"Hydes","year":"2023","journal-title":"BMC Med"},{"key":"2026091010265091000_bib27","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1681\/ASN.2007101155","article-title":"Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease","volume":"19","author":"Targher","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2026091010265091000_bib28","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"2026091010265091000_bib29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41581-024-00875-5","article-title":"Lymphocytes and innate immune cells in acute kidney injury and repair","volume":"20","author":"Lee","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2026091010265091000_bib30","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1111\/j.1600-6143.2006.01361.x","article-title":"Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant","volume":"6","author":"Myslak","year":"2006","journal-title":"Am J Transplant"},{"key":"2026091010265091000_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-6143.2004.00665.x","article-title":"Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation","volume":"5","author":"D\u2019Cunha","year":"2005","journal-title":"Am J Transplant"},{"key":"2026091010265091000_bib32","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1210\/clinem\/dgab339","article-title":"Metabolic dysfunction-Associated Fatty Liver Disease (MAFLD)-rather a bystander than a driver of mortality","volume":"106","author":"Semmler","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091010265091000_bib33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"2026091010265091000_bib34","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1681\/ASN.2020050566","article-title":"Death after kidney transplantation: an analysis by era and time post-transplant","volume":"31","author":"Ying","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026091010265091000_bib35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"2026091010265091000_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/3709409","article-title":"The Social Desirability Variable in Personality Assessment and Research","volume":"19","author":"Barry","year":"1958","journal-title":"The American Catholic Sociological Review"},{"key":"2026091010265091000_bib37","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1159\/000526118","article-title":"Nonalcoholic fatty liver disease before kidney transplantation correlates with new onset diabetes and poor metabolic outcomes","volume":"53","author":"Grupper","year":"2022","journal-title":"Am J Nephrol"},{"key":"2026091010265091000_bib38","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/hep.27362","article-title":"Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study","volume":"60","author":"Loomba","year":"2014","journal-title":"Hepatology"},{"key":"2026091010265091000_bib39","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"M\u00f3zes","year":"2022","journal-title":"Gut"},{"key":"2026091010265091000_bib40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3109\/0886022X.2012.713280","article-title":"Association of inflammatory biomarkers with metabolic syndrome in hemodialysis patients","volume":"34","author":"Shahrokh","year":"2012","journal-title":"Ren Fail"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag294\/70885299\/sfag294.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/9\/sfag294\/70885299\/sfag294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/9\/sfag294\/70885299\/sfag294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:26:57Z","timestamp":1789050417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag294\/8777106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag294","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,31]]},"article-number":"sfag294"}}